IRIS STENDIG-RASKIN: Open Payments
NPI 1144306242 · BRISTOL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 29 payments from 10 companies in 2025. Trend: 2023 $660 · 2024 $362 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 13 | $148 |
| Exeltis, USA Inc. | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| SHIELD THERAPEUTICS INC | 2 | $49 |
| Sage Therapeutics, LLC | 2 | $43 |
| Organon LLC | 1 | $33 |
| Exact Sciences Corporation | 2 | $29 |
| MIMEDX Group, Inc. | 1 | $26 |
| Evofem Biosciences, Inc. | 1 | $20 |
| CooperSurgical, Inc. | 1 | $17 |
Products named: SLYND, MYFEMBREE, ACCRUFER, ZURZUVAE, NEXPLANON, Cologuard Collection Kit, Phexxi, Paragard T 380A.
Industry payments across PA — which companies pay providers there.
